INO
Price
$2.29
Change
+$0.04 (+1.78%)
Updated
Dec 26 closing price
Capitalization
157.33M
Intraday BUY SELL Signals
ONWRF
Price
$5.35
Change
+$0.20 (+3.88%)
Updated
Dec 24 closing price
Capitalization
277.77M
Intraday BUY SELL Signals
Interact to see
Advertisement

INO vs ONWRF

Header iconINO vs ONWRF Comparison
Open Charts INO vs ONWRFBanner chart's image
Inovio Pharmaceuticals
Price$2.29
Change+$0.04 (+1.78%)
Volume$544.38K
Capitalization157.33M
Onward Med
Price$5.35
Change+$0.20 (+3.88%)
Volume$950
Capitalization277.77M
INO vs ONWRF Comparison Chart in %
View a ticker or compare two or three
VS
INO vs. ONWRF commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a StrongBuy and ONWRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (INO: $2.29 vs. ONWRF: $5.35)
Brand notoriety: INO: Notable vs. ONWRF: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 40% vs. ONWRF: 27%
Market capitalization -- INO: $157.33M vs. ONWRF: $277.77M
INO [@Biotechnology] is valued at $157.33M. ONWRF’s [@Biotechnology] market capitalization is $277.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileONWRF’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • ONWRF’s FA Score: 0 green, 5 red.
According to our system of comparison, INO is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 7 TA indicator(s) are bullish while ONWRF’s TA Score has 4 bullish TA indicator(s).

  • INO’s TA Score: 7 bullish, 3 bearish.
  • ONWRF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, INO is a better buy in the short-term than ONWRF.

Price Growth

INO (@Biotechnology) experienced а +0.44% price change this week, while ONWRF (@Biotechnology) price change was +3.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONWRF($278M) has a higher market cap than INO($157M). INO YTD gains are higher at: 28.652 vs. ONWRF (-10.833). ONWRF has higher annual earnings (EBITDA): -34.06M vs. INO (-105.08M). INO has more cash in the bank: 50.8M vs. ONWRF (40.9M). INO has less debt than ONWRF: INO (10M) vs ONWRF (15.1M). ONWRF has higher revenues than INO: ONWRF (1.26M) vs INO (182K).
INOONWRFINO / ONWRF
Capitalization157M278M56%
EBITDA-105.08M-34.06M309%
Gain YTD28.652-10.833-264%
P/E RatioN/AN/A-
Revenue182K1.26M14%
Total Cash50.8M40.9M124%
Total Debt10M15.1M66%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOONWRF
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
53%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
37%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
37%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signal:
Gain/Loss:
ONWRF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UIVQX12.770.03
+0.24%
MFS Intrinsic Value R4
PRJAX37.590.09
+0.24%
PGIM Jennison Global Opportunities A
PGICX17.94N/A
N/A
Virtus KAR Equity Income C
FGFRX44.83N/A
N/A
Federated Hermes Intl Leaders R
AWTIX18.66-0.02
-0.11%
Virtus Duff & Phelps Water Inst

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with AXON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+1.78%
AXON - INO
53%
Loosely correlated
-1.24%
ARRY - INO
52%
Loosely correlated
+0.39%
RPTX - INO
48%
Loosely correlated
+0.78%
ALNY - INO
42%
Loosely correlated
-0.02%
BTAI - INO
39%
Loosely correlated
-2.92%
More

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
-1.36%
UCBJF - ONWRF
23%
Poorly correlated
N/A
INO - ONWRF
22%
Poorly correlated
+1.78%
ACUT - ONWRF
8%
Poorly correlated
+16.34%
More